Article
The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers.
Breast cancer research and treatment - 1 Jun 2020
Obdeijn Inge-Marie, Mann Ritse M, Loo Claudette C E, Lobbes Marc, Voormolen Eleonora M C, van Deurzen Carolien H M, de Bock Geertruida, Hooning Maartje J
Abstract excerpt
PURPOSE: BRCA2 mutation carriers are offered annual breast screening with MRI and mammography. The aim of this study was to investigate the supplemental value of mammographic screening over MRI screening alone. METHODS: In this multicenter study, proven BRCA2 mutation carriers, who developed breast cancer during screening using both digital mammography and state-of-art breast MRI, were identified. Clinical data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.